ZA200902571B - Anticoagulant compounds - Google Patents

Anticoagulant compounds

Info

Publication number
ZA200902571B
ZA200902571B ZA200902571A ZA200902571A ZA200902571B ZA 200902571 B ZA200902571 B ZA 200902571B ZA 200902571 A ZA200902571 A ZA 200902571A ZA 200902571 A ZA200902571 A ZA 200902571A ZA 200902571 B ZA200902571 B ZA 200902571B
Authority
ZA
South Africa
Prior art keywords
anticoagulant compounds
anticoagulant
compounds
Prior art date
Application number
ZA200902571A
Other languages
English (en)
Inventor
Maurice Petitou
Guy Dubreucq
Olivier Querolle
Sandrine Zameo
Original Assignee
Endotis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endotis Pharma filed Critical Endotis Pharma
Publication of ZA200902571B publication Critical patent/ZA200902571B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA200902571A 2006-10-05 2009-04-15 Anticoagulant compounds ZA200902571B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06291556A EP1908768A1 (en) 2006-10-05 2006-10-05 Anticoagulant compounds

Publications (1)

Publication Number Publication Date
ZA200902571B true ZA200902571B (en) 2010-04-28

Family

ID=37946389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902571A ZA200902571B (en) 2006-10-05 2009-04-15 Anticoagulant compounds

Country Status (13)

Country Link
US (1) US20100081708A1 (xx)
EP (2) EP1908768A1 (xx)
JP (1) JP2010505813A (xx)
KR (1) KR20090074226A (xx)
CN (1) CN101535327A (xx)
AU (1) AU2007303858A1 (xx)
BR (1) BRPI0715269A2 (xx)
CA (1) CA2665392A1 (xx)
IL (1) IL197985A0 (xx)
MX (1) MX2009003576A (xx)
RU (1) RU2009116511A (xx)
WO (1) WO2008041131A2 (xx)
ZA (1) ZA200902571B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666318A (zh) * 2007-10-16 2015-06-03 普罗吉恩制药有限公司 新的硫酸化寡糖衍生物
JP6109574B2 (ja) 2009-12-18 2017-04-05 カタラン、フランス、バインハイム、ソシエテ、アノニムＣａｔａｌｅｎｔ Ｆｒａｎｃｅ Ｂｅｉｎｈｅｉｍ Ｓａ 合成オリゴサッカリドを含有する医薬経口剤形
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
JP6051211B2 (ja) * 2011-06-17 2016-12-27 カルボミメティクス 半減期が短く活性が高い合成五糖類

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
KR20090074226A (ko) 2009-07-06
RU2009116511A (ru) 2010-11-10
JP2010505813A (ja) 2010-02-25
WO2008041131A3 (en) 2008-05-29
WO2008041131A2 (en) 2008-04-10
CA2665392A1 (en) 2008-04-10
IL197985A0 (en) 2009-12-24
EP2074131A2 (en) 2009-07-01
BRPI0715269A2 (pt) 2013-06-04
MX2009003576A (es) 2009-06-17
US20100081708A1 (en) 2010-04-01
AU2007303858A1 (en) 2008-04-10
CN101535327A (zh) 2009-09-16
EP1908768A1 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
EP1984379A4 (en) ANTI-ARENAVIRAL COMPOUNDS
GB0605784D0 (en) Compounds
GB0605785D0 (en) Compounds
EP2082022A4 (en) COMPOUNDS
GB0606913D0 (en) Compounds
ZA200902571B (en) Anticoagulant compounds
EP2004174A4 (en) NAPHTHALENEDIONED COMPOUNDS
GB0602042D0 (en) Compounds
EP1973905A4 (en) COMPOUNDS
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (en) BISPYRIDINIUMVERBINDUNGEN
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0602558D0 (en) Compounds
GB0606084D0 (en) Compounds
GB0602451D0 (en) Compounds
GB0602454D0 (en) Compounds
GB0602455D0 (en) Compounds
GB0602040D0 (en) Compounds
GB0602559D0 (en) Compounds